FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to phenoxyphenylalkane sulfonates of the general formula (I): 
wherein R3 means alkyl group comprising from 4 to 7 carbon atoms and this group can be substituted from one to some times with fluorine or chlorine atom; A means oxygen atom or NH-group. Also, invention describes a method for preparing compounds of the formula (I) and medicinal agent based on thereof. Compounds can be used in treatment of pain syndromes and neurodegenerative diseases.
EFFECT: valuable medicinal properties of compounds.
7 cl, 3 tbl, 30 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS | 2011 |
|
RU2652638C2 |
| SUBSTITUTED OXAZOLIDINONES, METHODS FOR THEIR PREPARING, MEDICINAL AGENT BASED ON THEREOF AND USING SUBSTITUTED OXAZOLIDINONES | 2000 |
|
RU2297415C2 |
| COMBINED THERAPY USING SUBSTITUTED OXAZOLIDINONES | 2002 |
|
RU2321407C9 |
| COMPOUNDS WITH CONDENSED RINGS | 2019 |
|
RU2783414C2 |
| SPIRO CONDENSED DERIVATIVES OF 2,3-DIHYDROINDOLE, THEIR USE IN OPHTHALMOLOGY | 2017 |
|
RU2712039C2 |
| DERIVATIVES OF PYRIMIDINONE AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS, WHICH HAS PROPERTIES OF HUMAN NEUTROPHIL ELASTASE INHIBITOR | 2003 |
|
RU2376295C9 |
| NOVEL HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS | 2019 |
|
RU2769507C1 |
| BICYCLIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS | 2020 |
|
RU2811612C2 |
| BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS | 2016 |
|
RU2738232C2 |
| MACROHETEROCYCLIC NUCLEOSIDE DERIVATIVES AND ANALOGUES THEREOF, PRODUCTION AND USE | 2017 |
|
RU2731385C1 |
